AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 37 filers reported holding AN2 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,558,408 | +123.8% | 159,105 | +18.3% | 0.00% | +100.0% |
| Q2 2023 | $1,143,021 | -13.9% | 134,473 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,327,249 | +3.5% | 134,473 | -0.1% | 0.00% | 0.0% |
| Q4 2022 | $1,282,242 | -45.2% | 134,548 | +0.0% | 0.00% | -50.0% |
| Q3 2022 | $2,338,000 | +243.8% | 134,545 | +53.3% | 0.00% | +100.0% |
| Q2 2022 | $680,000 | – | 87,775 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,773,517 | $37,244,613 | 0.84% |
| Monashee Investment Management LLC | 247,467 | $2,442,499 | 0.67% |
| BVF INC/IL | 1,563,963 | $15,436,315 | 0.56% |
| Avidity Partners Management LP | 723,200 | $7,137,984 | 0.24% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 52,500 | $518,175 | 0.01% |
| Alyeska Investment Group, L.P. | 48,426 | $477,965 | 0.00% |
| Citadel Advisors | 1,337,159 | $13,197,759 | 0.00% |
| Private Advisor Group, LLC | 22,008 | $217,219 | 0.00% |
| ETF MANAGERS GROUP, LLC | 6,742 | $66,544 | 0.00% |
| CITIGROUP INC | 134,473 | $1,327,249 | 0.00% |